Pembrolizumab is now listed in the interaction checker as a cancer drug and interactions can be found with all the comedications.
Pembrolizumab (Keytruda®) is a monoclonal antibody and is indicated for the treatment of melanoma, non-small cell lung cancer and Hodgkin disease.
